Epigenetics impacts upon prognosis and clinical management of choroid plexus tumors

J Neurooncol. 2020 May;148(1):39-45. doi: 10.1007/s11060-020-03509-5. Epub 2020 Apr 28.


Purpose: Choroid plexus tumors comprise of choroid plexus papilloma (CPP, WHO grade I), atypical choroid plexus papilloma (aCPP, WHO grade II) and choroid plexus carcinoma (CPC, WHO grade III). Molecular events driving the majority of choroid plexus tumors remain poorly understood. Recently, DNA methylation profiling has revealed different epigenetic subgroups.

Methods: Comprehensive review of epigenetic profiles of choroid plexus tumors in the context of histopathological, genetic, and clinical features. DNA methylation profiling segregates choroid plexus tumors into three distinct epigenetic subgroups: supratentorial pediatric low-risk choroid plexus tumors (CPP and aCPP), infratentorial adult low-risk choroid plexus tumors (CPP and aCPP), and supratentorial pediatric high-risk choroid plexus tumors (CPP and aCPP and CPC). Epigenetic subgrouping provides additional prognostic information in comparison to histopathological grading.

Conclusions: Epigenetic profiling of choroid plexus tumors can be used for the identification of patients at risk of recurrence and is expected to play a role for treatment stratification and patient management in the context of future clinical trials.

Keywords: 850 k; Choroid plexus tumor; Copy number alterations; DNA methylation profiling; Prognosis; TP53; Treatment.

Publication types

  • Review

MeSH terms

  • Choroid Plexus Neoplasms* / diagnosis
  • Choroid Plexus Neoplasms* / genetics
  • Choroid Plexus Neoplasms* / therapy
  • DNA Methylation
  • Epigenesis, Genetic*
  • Humans
  • Prognosis

Grants and funding